Cytosorbents Announces 1-for-20 Reverse Stock Split, Effective September 8

Benzinga Newsdesk www.benzinga.com Positive 55.6%

Neg 0% Neu 0% Pos 55.6%

Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price Requirement
Expected to Become Effective and Trade on Split-Adjusted Basis at the Market Open on September 8, 2026

Comments

No comments yet. Be the first!